SLC43A1 and ovarian carcinoma: To determine if LAT3 expression plays a role in oxaliplatin resistance in ovarian cancer, we examined a panel of 1A9 ovarian cancer cells (derived from A2780 cells) that were selected with increasing concentrations of oxaliplatin ((26); Fig. 5A).